Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation

Clinical trial NCT05919537 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05919537
Sponsor: Hummingbird Bioscience
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Pancreatic Cancer Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2023-09-06
Primary completion: 2031-03-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.